Literature DB >> 10352253

Induction of T cell anergy by low numbers of agonist ligands.

L C Korb1, S Mirshahidi, K Ramyar, A A Sadighi Akha, S Sadegh-Nasseri.   

Abstract

Engagement of TCR by its ligand, the MHC/peptide complex, causes T cell activation. T cells respond positively to stimulation with agonists, and are inhibited by antagonist MHC/peptide ligands. Failure to induce proper conformational changes in the TCR or fast TCR/MHC dissociation are the leading models proposed to explain anergy induction by antagonist ligands. In this study, we demonstrate that presentation of between 1 and 10 complexes of agonist/MHC II by unfixed APC induces T cell anergy that persists up to 7 days and has characteristics similar to anergy induced by antagonist ligand or TCR occupancy without costimulation. Furthermore, anergy-inducing doses of hemagglutinin 306-318 peptide led to the engagement of less than 1000 TCR/CD3 complexes. Thus, engagement of a subthreshold number of TCR by either a low density of agonist/MHC or a 2-3 orders of magnitude higher density of antagonist/MHC causes anergy. Moreover, we show that anergy induced by low agonist concentrations is inhibited in the presence of IL-2 or cyclosporin A, suggesting involvement of the calcineurin signaling pathway.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10352253

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Use of multiple peptides containing T cell epitopes is a feasible approach for peptide-based immunotherapy in Can f 1 allergy.

Authors:  Anu K Immonen; Antti H Taivainen; Ale T O Närvänen; Tuure T Kinnunen; Soili A Saarelainen; Marja A Rytkönen-Nissinen; Tuomas I Virtanen
Journal:  Immunology       Date:  2007-01       Impact factor: 7.397

Review 2.  Manipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE.

Authors:  Joseph J Sabatino; Kristen M Rosenthal; Brian D Evavold
Journal:  J Neuroimmune Pharmacol       Date:  2009-11-11       Impact factor: 4.147

3.  Blomia tropicalis allergen 5 (Blo t 5) T-cell epitopes and their ability to suppress the allergic immune response.

Authors:  Kenneth H Wong; Qian Zhou; Nayana Prabhu; Kazuki Furuhashi; Yen Leong Chua; Gijsbert M Grotenbreg; David M Kemeny
Journal:  Immunology       Date:  2017-07-17       Impact factor: 7.397

4.  Suboptimal stimulation by weak agonist epitope variants does not drive dysfunction of HIV-1-specific cytotoxic T lymphocyte clones.

Authors:  Mark A Grossman; Christian Hofmann; Hwee L Ng; Otto O Yang
Journal:  AIDS       Date:  2019-08-01       Impact factor: 4.177

Review 5.  Suboptimal engagement of the T-cell receptor by a variety of peptide-MHC ligands triggers T-cell anergy.

Authors:  Scheherazade Sadegh-Nasseri; Sarat K Dalai; Laura C Korb Ferris; Saied Mirshahidi
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

6.  Multiple genetic programs contribute to CD4 T cell memory differentiation and longevity by maintaining T cell quiescence.

Authors:  Nianbin Song; Srona Sengupta; Stanislav Khoruzhenko; Robin A Welsh; AeRyon Kim; Mithra R Kumar; Søren Ulrik Sønder; John-William Sidhom; Hao Zhang; Chunfa Jie; Robert F Siliciano; Scheherazade Sadegh-Nasseri
Journal:  Cell Immunol       Date:  2020-09-05       Impact factor: 4.868

Review 7.  Molecular regulation of T-cell anergy.

Authors:  Yan Zheng; Yuanyuan Zha; Thomas F Gajewski
Journal:  EMBO Rep       Date:  2008-01       Impact factor: 8.807

8.  Destabilization of peptide:MHC interaction induces IL-2 resistant anergy in diabetogenic T cells.

Authors:  Lindsay J Edwards; Brian D Evavold
Journal:  J Autoimmun       Date:  2013-07-26       Impact factor: 7.094

9.  Anergy in memory CD4+ T cells is induced by B cells.

Authors:  Sarat K Dalai; Saied Mirshahidi; Alexandre Morrot; Fidel Zavala; Scheherazade Sadegh-Nasseri
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

10.  Chronic inhaled ovalbumin exposure induces antigen-dependent but not antigen-specific inhalational tolerance in a murine model of allergic airway disease.

Authors:  Craig M Schramm; Lynn Puddington; Carol Wu; Linda Guernsey; Mehrnaz Gharaee-Kermani; Sem H Phan; Roger S Thrall
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.